Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
HeartMetrics
AddedFeb 18, 2024
UpdatedJun 18, 2026
HeartMetrics

HeartMetrics

Angel

HeartMetrics offers automated, non-invasive diagnostic tech to identify and quantify coronary diseases.

HQ
Baltimore, MD, US
Founded
2014
Overview
Compare
Fundraising
Employees

Founded with a mission to revolutionize cardiac diagnostics, HeartMetrics specializes in developing automated, non-invasive diagnostic algorithms to assess coronary blood flow. Their flagship technology, TAFE TM, leverages contrast dispersion fluid dynamics to analyze standard computed tomography angiography (CTA) images, enabling rapid and accurate identification of coronary diseases that impede blood flow to the heart muscle. By focusing on non-invasive methods, HeartMetrics aims to enhance early detection and treatment of cardiovascular conditions.

HeartMetrics has garnered attention from notable figures and investors in the medical and tech industries, contributing to its credibility and growth. The company’s innovative approach has led to significant achievements in the field of cardiac diagnostics, making it a valuable player in the healthcare market. Through its advanced technology, HeartMetrics has made a substantial impact on improving diagnostic accuracy and patient outcomes in cardiology.

HeartMetrics - Similar Companies

Vital Metrix logo

Vital Metrix

Heartio logo

Heartio

heartio.ai

Cardiac Insight logo

Cardiac Insight

Heartflow logo

Heartflow

CardioWise logo

CardioWise

cardiowiseinc.com

InvisionHeart logo

InvisionHeart

invisionheart.com

Cardiac Motion logo

Cardiac Motion

HeartVista logo

HeartVista

Cardiodiagnostics logo

Cardiodiagnostics

AngioInsight logo

AngioInsight

angioinsight.com

Avicena logo

Avicena

avicenaheart.com

Corscans logo

Corscans

Cardiovip logo

Cardiovip

Atriomx logo

Atriomx

Cleerly logo

Cleerly

cleerlyhealth.com

HeartMetrics - Quick Facts

Who are HeartMetrics' competitors?

Companies similar to HeartMetrics include Vital Metrix, Heartio, Cardiac Insight and Heartflow.

When was HeartMetrics founded?

HeartMetrics was founded in 2014.

Where is HeartMetrics' headquarters located?

HeartMetrics' headquarters is located in Baltimore, MD, US.

When was HeartMetrics' last funding round?

HeartMetrics' most recent funding round was for $150k (USD) in June 2015.

How much has HeartMetrics raised to-date?

As of Jun 26, 2015, HeartMetrics has raised a total of $150k (USD).

How many employees does HeartMetrics have?

HeartMetrics has 6 employees as of Feb 4, 2024.

HeartMetrics - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Diagnostic Algorithms
Tags
  • Biotech
  • Data Information
  • Healthcare
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified